Lv740
3850 积分 2023-05-26 加入
Replication stress and cancer
11天前
已完结
Blocking LBH expression causes replication stress and sensitizes triple-negative breast cancer cells to ATR inhibitor treatment
13天前
已完结
帕金森病治疗指南
15天前
已完结
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
15天前
已关闭
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
22天前
已完结
Immunologic and Molecular Mechanisms in Inflammatory Bowel Disease
23天前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
23天前
已完结
Augmenting DMTA using predictive AI modelling at AstraZeneca
1个月前
已完结
Circulating Tumor DNA (ctDNA) for Plasma Genotyping and Disease Monitoring in ALK-Positive Anaplastic Lymphoma (ALK+ALCL): A Proof of Concept Study
1个月前
已完结
Circulating Tumor DNA (ctDNA) for Plasma Genotyping and Disease Monitoring in ALK-Positive Anaplastic Lymphoma (ALK+ALCL): A Proof of Concept Study
1个月前
已关闭
皖公网安备34019202002308
